Home/ Supplements/ Reishi/ Shiitake Maitake Reishi 600 mg

Shiitake Maitake Reishi 600 mg

product on market Capsule tnvitamins Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Shiitake Maitake Reishi 600 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Maitake Mushroom
200 mg
Market median: 340.0mg (243 products) 3 studies — no high-quality reviews
Shiitake Mushroom
200 mg

Other Ingredients

Gelatin Magnesium Stearate Microcrystalline Cellulose Silica
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions: As a dietary supplement for adults, take one (1) capsule daily, or as directed by a healthcare professional.

Warnings & Precautions

Caution: Pregnant or lactating women should consult a doctor before use.

If you are under medical supervision, please consult a doctor before use. Discontinue use and consult a doctor if any adverse reactions occur.

Keep out of reach of children.

Formulation Notes

Free of: gluten, wheat, yeast, soy, peanuts, tree nuts, fish, sugar, crustaceans, & dairy. No artificial colors or flavors. Non-GMO.

Mushroom trio complex oom extract powder caps

Shiitake Maitake Reishi 600 mg per serving Equivalent from 20 mg each of maitake, reishi, & shiitake 10:1 mushroom extracts.

Non GMO Gluten free Nuts free

100% natural

Additional Information

Store in a cool, dry place.

New

Packaged & lab tested in the USA

Metadata

Product Details

UPC / SKUX003BBEEP1
DSLD Entry Date2024-07-25
Product TypeBotanical
FormCapsule
DSLD ID314555
Data Updated2026-04-11
Research

Research Evidence

6
Research Sources
60
Avg Quality
3
Meta Analysis
3
Rct
B Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Ganoderma lucidum (Reishi mushroom) for cancer treatment
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Ganoderma lucidum (Reishi mushroom) for cancer treatment
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
C Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients
Rct Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 PubMed DOI
C Efficacy of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Supplementation on Psychological Stress and Selective Fitness Profile Parameters in Female College Students in West Bengal, India
Rct International journal of medicinal mushrooms 2024 PubMed DOI
C Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial
Rct Integrative cancer therapies 2020 PubMed DOI
View all evidence for Reishi →
Compare

Similar Products

View all Reishi products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.